Faron "Very Encouraged" By Early Clevegen Trials In Cancer Patients
LONDON (Alliance News) - Faron Pharmaceuticals Ltd on Thursday said early results from a trial of its Clevegen cancer drug are encouraging.Shares in Faron were up 10% at 64.00 pence on said Read More